Gaviscon Suspension
- Name:
Gaviscon Suspension
- Company:
Reckitt Benckiser Ireland Limited
- Active Ingredients:
- Legal Category:
Supply through pharmacy only
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 15/01/20


Print ViewKeyword Search SPC
1. NAME OF THE MEDICINAL PRODUCT
1. NAME OF THE MEDICINAL PRODUCT
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
3. PHARMACEUTICAL FORM
3. PHARMACEUTICAL FORM
4. CLINICAL PARTICULARS
4. CLINICAL PARTICULARS
5. PHARMACOLOGICAL PROPERTIES
5. PHARMACOLOGICAL PROPERTIES
6. PHARMACEUTICAL PARTICULARS
6. PHARMACEUTICAL PARTICULARS
7. MARKETING AUTHORISATION HOLDER
7. MARKETING AUTHORISATION HOLDER
8. MARKETING AUTHORISATION NUMBER(S)
8. MARKETING AUTHORISATION NUMBER(S)
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
10. DATE OF REVISION OF THE TEXT
10. DATE OF REVISION OF THE TEXT
Reckitt Benckiser Ireland Limited

Company Products
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 15 January 2020 PIL
Reasons for updating
- New PIL for new product
Updated on 20 April 2016 SPC
Reasons for updating
- New SPC for new product
Legal category: Supply through pharmacy only
Updated on 20 April 2016 SPC
Reasons for updating
- Change to section 6.5 - Nature and contents of container
Legal category: Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
Updated on 20 April 2016 PIL
Reasons for updating
- Change to section 6.5 - Nature and contents of container
Free text change information supplied by the pharmaceutical company
Updated on 17 April 2014 SPC
Reasons for updating
- Change to section 4.2 - Posology and method of administration
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.6 - Pregnancy and lactation
- Change to section 4.7 - Effects on ability to drive and use machines
- Change to section 4.8 - Undesirable effects
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 10 - Date of revision of the text
Legal category: Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
Section 4.3 - added contraindication for hypersensitivity to active ingredients and excipients
Section 4.4 - added statement regarding calcium and statement to limit treatment duration as much as possible
Section 4.5 - added a 2 hour time interval between taking Gaviscon and other specified products
Section 4.6 - added more detailed information on taking Gaviscon for Pregnancy, breastfeeding, and fertility
Section 4.7 - Updated wording
Section 4.8 - updated frequencies
Section 5.1 - added pharmacotherapeutic group
Section 10 - Changed Date of revision of text
Updated on 17 April 2014 PIL
Reasons for updating
- Change to section 4.2 - Posology and method of administration
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.6 - Pregnancy and lactation
- Change to section 4.7 - Effects on ability to drive and use machines
- Change to section 4.8 - Undesirable effects
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 10 - Date of revision of the text
Free text change information supplied by the pharmaceutical company
Section 4.3 - added contraindication for hypersensitivity to active ingredients and excipients
Section 4.4 - added statement regarding calcium and statement to limit treatment duration as much as possible
Section 4.5 - added a 2 hour time interval between taking Gaviscon and other specified products
Section 4.6 - added more detailed information on taking Gaviscon for Pregnancy, breastfeeding, and fertility
Section 4.7 - Updated wording
Section 4.8 - updated frequencies
Section 5.1 - added pharmacotherapeutic group
Section 10 - Changed Date of revision of text
Updated on 13 December 2012 PIL
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
Free text change information supplied by the pharmaceutical company
Updated on 13 December 2012 SPC
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
Legal category: Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
Updated on 17 April 2012 PIL
Reasons for updating
- Change to section 9 - Date of renewal of authorisation
- Change to section 10 - Date of revision of the text
Free text change information supplied by the pharmaceutical company
Updated to amend section 10 date of revsion of text to September 2008
Updated on 17 April 2012 SPC
Reasons for updating
- Change to section 9 - Date of renewal of authorisation
- Change to section 10 - Date of revision of the text
Legal category: Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
Updated to amend section 10 date of revsion of text to September 2008
Updated on 18 December 2008 PIL
Reasons for updating
- Change to section 1 - Name of medicinal product
- Change to section 9 - Date of renewal of authorisation
Free text change information supplied by the pharmaceutical company
Updated on 18 December 2008 SPC
Reasons for updating
- Change to section 1 - Name of medicinal product
- Change to section 9 - Date of renewal of authorisation
Legal category: Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
Updated on 15 May 2007 PIL
Reasons for updating
- Change to section 4.8 - Undesirable effects
- Change to marketing authorisation holder address
Free text change information supplied by the pharmaceutical company
Updated on 15 May 2007 SPC
Reasons for updating
- Change to section 4.8 - Undesirable effects
- Change to marketing authorisation holder address
Legal category: Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
Updated on 1 July 2005 PIL
Reasons for updating
- Change to section 6.3 - Shelf life
Updated on 1 July 2005 SPC
Reasons for updating
- Change to section 6.3 - Shelf life
Legal category: Supply through pharmacy only
Updated on 20 May 2005 SPC
Reasons for updating
- Improved electronic presentation
Legal category: Supply through pharmacy only
Updated on 20 May 2005 PIL
Reasons for updating
- Improved electronic presentation
Updated on 11 August 2004 PIL
Reasons for updating
- Improved electronic presentation
Updated on 11 August 2004 SPC
Reasons for updating
- Improved electronic presentation
Legal category: Supply through pharmacy only
Updated on 16 June 2003 SPC
Reasons for updating
- New SPC for medicines.ie
Legal category: Supply through pharmacy only
Updated on 16 June 2003 PIL
Reasons for updating
- New SPC for medicines.ie